Enabling GLP-1 Commercial Success through Drug Device Readiness

11:30 am - Thursday 16th April 2026

  • Drug–device readiness is now a commercial differentiator for GLP-1s
  • An integrated Formulation Development–DP–device model reduces risk and timelines
  • Early device strategy unlocks scalable growth

Speakers:

Vice President - Business Development
One Source Co.
AVP – Business Development
One Source Co.